Global Peptide Drug Conjugate Clinical Trial Market By Phase (Phase 1, Phase 2, Phase 3, Others); By Indication (Cancer – Breast Cancer, Prostate Cancer, Lung Cancer, Metastatic Endometrial Cancer, Epithelial Ovarian Cancer, Others, Diabetes, Hypoglycemia, Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Report ID :AMI-1227 | Category : Healthcare | Published Date : August, 2022 | Pages : 402 | Format :PDF

Enquiry Before Buying